Reintervention and Survival After Transcatheter Pulmonary Valve Replacement

McElhinney, Doff B.; Zhang, Yulin; Levi, Daniel S.; Georgiev, Stanimir; Biernacka, Elżbieta Katarzyna; Goldstein, Bryan H; Shahanavaz, Shabana; Qureshi, Athar M.; Cabalka, Allison K.; Bauser‐Heaton, Holly; Torres, Alejandro; Morray, Brian H.; Armstrong, Aimee K.; Millán-Iturbe, Óscar; Peng, Lynn F.; Aboulhosn, Jamil; Rużyłło, Witold; Berger, Felix; Søndergaard, Lars; Schranz, Dietmar; Cheatham, John P.; Jones, Thomas K.; Ewert, Peter; Schubert, Stephan

doi:10.1016/j.jacc.2021.10.031

Cited by 45 publications

(25 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…TPVI is an effective treatment alternative to surgical pulmonary valve replacement for patients with right ventricular dysfunction after correction of TOF (7)(8)(9)(10). IE of TPVI is a dreadful complication and associated with a relevant need of re-intervention (11).…”

Section: Discussionmentioning

confidence: 99%

Case report: Transcatheter pulmonary valve-in-valve implantation in a deteriorated self-expandable valve caused by infective endocarditis

Pan

Wang

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

BackgroundInfective endocarditis is a complication with high mortality in patients with congenital heart disease, particularly for those with bioprosthetic valve.Case summaryWe report a case of a 54-year-old female with a history of tetralogy of Fallot who had been surgically repaired using a transannular patch due to severe pulmonary insufficiency with right heart enlargement and presented with worsening dyspnea. She had received transcatheter pulmonary valve implantation (TPVI) 5 years ago. Unfortunately, bioprosthesis-associated infective endocarditis occurred due to dental caries. Given persistent antibiotic medication, she became clinically stable with prosthesis functional recovery. However, dysfunctional bioprosthesis was still detected 3 years later, which was successfully treated by valve-in-valve TPVI with the help of modified buddy wire technique. At a 12-month follow-up after valve-in-valve TPVI, she was completely recovered with improved symptoms of heart failure.ConclusionThis is the first report of valve-in-valve TPVI of a self-expandable valve in a degenerated self-expandable valve. The case highlights increased surveillance for infective endocarditis of transcatheter pulmonary valve should be emphasized. Subsequent valve-in-valve TPVI is an effective treatment for valve failure in defined conditions improving the hemodynamics.

show abstract

Section: Discussionmentioning

confidence: 99%

Case report: Transcatheter pulmonary valve-in-valve implantation in a deteriorated self-expandable valve caused by infective endocarditis

Pan

Wang

et al. 2022

Front. Cardiovasc. Med.

View full text Add to dashboard Cite

show abstract

“…[19][20][21] However, IE has emerged as a threat to valve longevity, with most data sets reporting annualized incidence rates of IE of approximately 2% after Melody implantation, but some studies have documented annualized rates as high as >4%. 22,23 Q11 The largest studies of balloon-expandable valves (which included both the Melody valve and SAPIEN THV) by McElhinney et al 24,25 showed comparable rates of survival and reintervention to surgically placed valves with an incidence of endocarditis of 16.9% at 8 years. It has been very difficult to compare the Melody valve with the SAPIEN THV, as these comparisons are confounded by the differing landing zones and patient populations: the Melody valve is much more commonly used in conduits and BPVs versus native landing zones for the SAPIEN THV.…”

Section: Clinical Experiencementioning

confidence: 99%

Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies

Patel¹,

Levi²,

Cheatham³

et al. 2022

Journal of the Society for Cardiovascular Angiography & Int

Self Cite

View full text Add to dashboard Cite

“…Transcatheter procedures are increasingly utilized as an equally effective alternative to surgical intervention in pulmonary valve disease. 77,78 Indications for transcatheter pulmonary valve replacement (TPVR) include severe pulmonary valve stenosis and moderate-to-severe pulmonary valve regurgitation with right ventricular disfunction. Currently, a right ventricular end-systolic volume (RVESV) less than 82-90 ml/m 2 or a right ventricular ejection fraction less than 30% is used as a marker for right ventricular disfunction.…”

Section: Pulmonary Valvementioning

confidence: 99%

“…Transcatheter procedures are increasingly utilized as an equally effective alternative to surgical intervention in pulmonary valve disease 77,78 . Indications for transcatheter pulmonary valve replacement (TPVR) include severe pulmonary valve stenosis and moderate-to-severe pulmonary valve regurgitation with right ventricular disfunction.…”

Section: Pulmonary Valvementioning

confidence: 99%

Role of computed tomography in transcatheter replacement of ‘other valves’: a comprehensive review of preprocedural imaging

Pugliese

Ricci

Luciano

et al. 2022

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

Transcatheter procedures for heart valve repair or replacement represent a valid alternative for treating patients who are inoperable or at a high risk for open-heart surgery. The transcatheter approach has become predominant over surgical intervention for aortic valve disease, but it is also increasingly utilized for diseases of the ‘other valves’, that is the mitral and, to a lesser extent, tricuspid and pulmonary valve. Preprocedural imaging is essential for planning the transcatheter intervention and computed tomography has become the main imaging modality by providing information that can guide the type of treatment and choice of device as well as predict outcome and prevent complications. In particular, preprocedural computed tomography is useful for providing anatomic details and simulating the effects of device implantation using 3D models. Transcatheter mitral valve replacement is indicated for the treatment of mitral regurgitation, either primary or secondary, and computed tomography is crucial for the success of the procedure. It allows evaluating the mitral valve apparatus, the surrounding structures and the left heart chambers, identifying the best access route and the landing zone and myocardial shelf, and predicting obstruction of the left ventricular outflow tract, which is the most frequent postprocedural complication. Tricuspid valve regurgitation with or without stenosis and pulmonary valve stenosis and regurgitation can also be treated using a transcatheter approach. Computer tomography provides information on the tricuspid and pulmonary valve apparatus, the structures that are spatially related to it and may be affected by the procedure, the right heart chambers and the right ventricular outflow tract.

show abstract

Reintervention and Survival After Transcatheter Pulmonary Valve Replacement

Cited by 45 publications

References 34 publications

Case report: Transcatheter pulmonary valve-in-valve implantation in a deteriorated self-expandable valve caused by infective endocarditis

Case report: Transcatheter pulmonary valve-in-valve implantation in a deteriorated self-expandable valve caused by infective endocarditis

Transcatheter Pulmonary Valve Replacement: A Review of Current Valve Technologies

Role of computed tomography in transcatheter replacement of ‘other valves’: a comprehensive review of preprocedural imaging

Contact Info

Product

Resources

About